Actinomycin Supplier-Buyer Network — Trade Flow Analysis

Name: Actinomycin Supplier-Buyer Trade Network Dataset — 184+ Indian Exporters, 13+ Importers, 97+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Actinomycin supplier network, Actinomycin buyers, pharmaceutical export India, Actinomycin trade data

TransData Nexus

Actinomycin

India Pharmaceutical Trade Intelligence

$2.9M184 Suppliers97 CountriesHS 30049046

ExportsIndia → UNITED STATES73.5%India → BRAZIL8.4%

ImportsUNITED STATES → India$114

#1 Supplier: EUGIA PHARMA #1 Buyer: EUGIA US

Who Supplies Actinomycin? Top Manufacturers & Buyers 2026 — EUGIA PHARMA SPECIALITIES LIMITED Leads | TransData Nexus | TransData Nexus

1EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the first-largest Actinomycin exporter from India, with a market share of 61.4% and a total export value of $1.8M across 5 shipments. Their average shipment value of $360.3K is above the market average of $3.1K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 2 named buyers in our database. EUGIA US LLC is the dominant customer, accounting for 58.1% of this supplier's tracked business. Top customers include:

• EUGIA US LLC — $1.0M across 3 shipments (58.1% of this supplier's total exports)

• EUGIA US LLC — $754.4K across 2 shipments (41.9% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $360.3K is 11362% above the market average of $3.1K, consistent with large-order contracts or value-added formulations.

2IKRIS PHARMA NETWORK PRIVATE LIMITED

IKRIS PHARMA NETWORK PRIVATE LIMITED is the second-largest Actinomycin exporter from India, with a market share of 3.4% and a total export value of $100.6K across 103 shipments. Their average shipment value of $977 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.

IKRIS PHARMA NETWORK PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF, is the dominant customer, accounting for 63.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF, — $63.4K across 65 shipments (63.0% of this supplier's total exports)

• TO THE ORDER OF, — $19.2K across 20 shipments (19.1% of this supplier's total exports)

• To The Order — $8.4K across 9 shipments (8.4% of this supplier's total exports)

• SANTA CASA DE MISERI — $6.6K across 7 shipments (6.6% of this supplier's total exports)

• TO THE ORDER OF,ALEX — $3.0K across 3 shipments (3.0% of this supplier's total exports)

Key Insight: IKRIS PHARMA NETWORK PRIVATE LIMITED operates with high shipment frequency (103 shipments) at a per-shipment value of $977, indicating a broad distribution network with many smaller, regular orders.

3VAMA LIFECARE PRIVATE LIMITED

VAMA LIFECARE PRIVATE LIMITED is the third-largest Actinomycin exporter from India, with a market share of 1.5% and a total export value of $44.1K across 59 shipments. Their average shipment value of $747 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.

VAMA LIFECARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE — $18.0K across 24 shipments (40.9% of this supplier's total exports)

• EXP CODE — $10.2K across 14 shipments (23.0% of this supplier's total exports)

• TO THE — $7.9K across 11 shipments (17.9% of this supplier's total exports)

• AS PER INVOICE BRAZI — $7.4K across 10 shipments (16.9% of this supplier's total exports)

• AS PER INVOICE — $588 across 1 shipments (1.3% of this supplier's total exports)

Key Insight: VAMA LIFECARE PRIVATE LIMITED operates with high shipment frequency (59 shipments) at a per-shipment value of $747, indicating a broad distribution network with many smaller, regular orders.

4CELON LABORATORIES PRIVATE LIMITED

CELON LABORATORIES PRIVATE LIMITED is the fourth-largest Actinomycin exporter from India, with a market share of 1.1% and a total export value of $33.0K across 16 shipments. Their average shipment value of $2.1K is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.

CELON LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SEVEN PHARMA LTDA — $7.8K across 4 shipments (23.7% of this supplier's total exports)

• VERNON TECHNOLOGIES — $7.8K across 4 shipments (23.5% of this supplier's total exports)

• DRAGON PHARMACEUTICA — $6.2K across 3 shipments (18.8% of this supplier's total exports)

• SEVEN PHARMA EL SALV — $5.8K across 3 shipments (17.7% of this supplier's total exports)

• SEVEN PHARMA S.A.C. — $5.4K across 3 shipments (16.3% of this supplier's total exports)

Key Insight: CELON LABORATORIES PRIVATE LIMITED operates with high shipment frequency (16 shipments) at a per-shipment value of $2.1K, indicating a broad distribution network with many smaller, regular orders.

5GNH INDIA PHARMACEUTICALS LIMITED

GNH INDIA PHARMACEUTICALS LIMITED is the fifth-largest Actinomycin exporter from India, with a market share of 0.9% and a total export value of $25.1K across 56 shipments. Their average shipment value of $448 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.

GNH INDIA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 64.6% of this supplier's tracked business. Top customers include:

• TO THE ORDER — $16.2K across 36 shipments (64.6% of this supplier's total exports)

• TO THE ORDER — $4.8K across 11 shipments (19.2% of this supplier's total exports)

• TO — $2.3K across 5 shipments (9.2% of this supplier's total exports)

• WORLD MEDIC SERVICOS — $1.1K across 3 shipments (4.6% of this supplier's total exports)

• HOSPITAL SAO RAFAEL — $623 across 1 shipments (2.5% of this supplier's total exports)

Key Insight: GNH INDIA PHARMACEUTICALS LIMITED operates with high shipment frequency (56 shipments) at a per-shipment value of $448, indicating a broad distribution network with many smaller, regular orders.

6MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Actinomycin exporter from India, with a market share of 0.0% and a total export value of $0 across 4 shipments. Their average shipment value of $0 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.

Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (4 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Actinomycin imports from India, with a total trade value of $2.2M across 9 shipments — representing a 73.5% share of all Actinomycin exports. The average shipment value of $239.5K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Actinomycin importers in United States: EUGIA US LLC is the largest buyer, accounting for 48.6% ($1.0M) of this market's total imports.

• EUGIA US LLC — $1.0M (48.6% of United States's total)

• EUGIA US LLC, — $754.4K (35.0% of United States's total)

• AUROLOGISTIC LLC — $348.8K (16.2% of United States's total)

Key Insight: United States's per-shipment average of $239.5K (7522% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Actinomycin imports from India.

Primary Market

Secondary Market

2Brazil

Brazil ranks as the second-largest destination for Actinomycin imports from India, with a total trade value of $245.8K across 61 shipments — representing a 8.4% share of all Actinomycin exports. The average shipment value of $4.0K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Actinomycin importers in Brazil: TO THE is the largest buyer, accounting for 10.2% ($25.0K) of this market's total imports.

• TO THE — $25.0K (10.2% of Brazil's total)

• EXP CODE — $10.2K (4.1% of Brazil's total)

• TO THE MANAGER- — $8.1K (3.3% of Brazil's total)

Key Insight: Brazil's per-shipment average of $4.0K (28% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Actinomycin imports from India.

Primary Market

Secondary Market

3Uganda

Uganda ranks as the third-largest destination for Actinomycin imports from India, with a total trade value of $37.6K across 3 shipments — representing a 1.3% share of all Actinomycin exports. The average shipment value of $12.5K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Actinomycin importers in Uganda: ONCOPHARM SPECIALITY PHARMACY is the largest buyer, accounting for 88.5% ($33.2K) of this market's total imports.

• ONCOPHARM SPECIALITY PHARMACY — $33.2K (88.5% of Uganda's total)

Key Insight: Uganda's per-shipment average of $12.5K (299% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Uganda is a key market for Actinomycin imports from India.

Primary Market

Secondary Market

4Ethiopia

Ethiopia ranks as the fourth-largest destination for Actinomycin imports from India, with a total trade value of $36.0K across 2 shipments — representing a 1.2% share of all Actinomycin exports. The average shipment value of $18.0K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Actinomycin importers in Ethiopia: ETHIOPIAN PHARMACEUTICALS is the largest buyer, accounting for 70.6% ($25.4K) of this market's total imports.

• ETHIOPIAN PHARMACEUTICALS — $25.4K (70.6% of Ethiopia's total)

Key Insight: Ethiopia's per-shipment average of $18.0K (473% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ethiopia is a key market for Actinomycin imports from India.

Primary Market

Secondary Market

5United Arab Emirates

United Arab Emirates ranks as the fifth-largest destination for Actinomycin imports from India, with a total trade value of $31.3K across 0 shipments — representing a 1.1% share of all Actinomycin exports. The average shipment value of $31.3K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: United Arab Emirates's per-shipment average of $31.3K (898% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Actinomycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Actinomycin.
2.Flow Mapping: 184 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 933 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

933 Verified Shipments

184 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Actinomycin

Actinomycin

Who Supplies Actinomycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Actinomycin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Actinomycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Actinomycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1EUGIA PHARMA SPECIALITIES LIMITED

2IKRIS PHARMA NETWORK PRIVATE LIMITED

3VAMA LIFECARE PRIVATE LIMITED

4CELON LABORATORIES PRIVATE LIMITED

5GNH INDIA PHARMACEUTICALS LIMITED

6MYLAN LABORATORIES LIMITED

From Indian Factories to Global Pharmacies — How Actinomycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Actinomycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Brazil

3Uganda

4Ethiopia

5United Arab Emirates

People Also Ask — Actinomycin Supplier & Trade Network

Actinomycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology